Ra Capital Management, L.P. Protara Therapeutics, Inc. Transaction History
Ra Capital Management, L.P.
- $4.58 Billion
- Q2 2025
A detailed history of Ra Capital Management, L.P. transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 1,039,295 shares of TARA stock, worth $3.19 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
1,039,295
Previous 3,400,000
69.43%
Holding current value
$3.19 Million
Previous $14.5 Million
78.26%
% of portfolio
0.07%
Previous 0.3%
Shares
3 transactions
Others Institutions Holding TARA
# of Institutions
81Shares Held
27.7MCall Options Held
37.2KPut Options Held
65.1K-
Janus Henderson Group PLC London, X04.1MShares$12.6 Million0.01% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA2.14MShares$6.57 Million11.14% of portfolio
-
Blackstone Inc New York, NY1.91MShares$5.86 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$5.53 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$5.38 Million3.47% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $34.6M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...